Problems › Hiring a Strategic Planning Consultant › Healthcare Providers
A plan lists activities across attributed lives while a decision would set which value-based contracts to accept or exit based on cost per episode. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.
A plan lists activities across attributed lives while a decision would set which value-based contracts to accept or exit based on cost per episode. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.
Each year clinical and operational groups submit requests for added panel capacity or support staff, the totals exceed available contribution per provider, and the difference is trimmed across the board so the published document shows activity levels rather than a choice between payer mixes or contract types.
A consultant is brought in to surface the missing cost-per-episode data that would allow the CFO or medical director to evaluate which attributed lives are sustainable, yet the real obstacle is that any explicit reduction in panel size or exit from a contract imposes a visible loss on one service line or another.
The second reason for outside help is the sheer work of pulling five years of episode costs, segmenting them by payer mix, and calculating contribution per provider while the same leaders continue to manage daily operations; this analytical assembly is where an external party still adds measurable hours even though much of the underlying arithmetic can now be automated.
Corporate Strategy & Transformation builds those segmented cases and shows what each contract or panel adjustment would require to hold, without running meetings or compelling the medical director and CFO to accept the political cost of shrinking attributed lives under any given value-based arrangement.
These three together are the signature. One on its own usually points somewhere else.
✓ The most recent planning cycle produced no explicit change to panel size or payer mix despite known shortfalls in cost-per-episode data on the 38,000 attributed lives.
✓ The same list of value-based contract improvements appears each year with no recorded progress on contribution per provider or episode-level costing.
✓ Budget allocations for the coming year are finalized before any recalculation of which contracts or panels can be sustained at current cost per episode.
The move that usually makes it worse. Bringing in a facilitator to improve the meeting flow when the actual barrier is the authority to require the CFO or medical director to shrink panel size or drop contracts once the cost-per-episode numbers are visible.
It is for you if you run or finance a healthcare provider and the last plan contained no decision to stop doing something. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Protect and grow the 34% operating-income ASC engine by replacing retiring surgeons and steering 212k attributed lives to the ASC within 24 months.
| Investment required | $3.0-4.0M total over 24 months ($1.8-2.2M surgeon succession + retention bonuses; $1.2-1.8M referral-optimization platform and analytics) |
| Expected return | Incremental $4.8-6.4M annual ASC contribution margin by Month 24; payback 14-18 months on $3.0-4.0M investment; lifts group operating margin from 4.2% to 5.8-6.4%. |
| Revenue, year 1 | $202-208M (ASC case volume +4-6%) |
| Revenue, year 2 | $212-220M (ASC case volume +6-8%; physician retention +2-3%) |
| Revenue, year 3 | $225-235M (ASC contribution ≥40% of operating income) |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than two qualified orthopaedic surgeon candidates have signed LOIs OR if ASC case volume has not grown at least 2% YoY; in either case, board must decide within 30 days whether to pivot to hospital-system sale process at 8-10× EBITDA. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
An independent facilitator running an offsite and producing a plan is commonly £8k–£30k. A firm running a full planning cycle with analysis is £60k–£200k. The range is wide because the two jobs are different: one is facilitation, one is evidence. Decide which you are short of before you compare quotes, because the cheap version of the wrong one is still wasted.
Short enough that the trade-offs are visible. A useful plan states where you will win, what you will stop, and the two or three things that must be true. Most of the length in a typical planning document is evidence supporting decisions that were already made, which belongs in an appendix nobody needs to read twice.
Set direction over three and commit resource over one. Three-year financial detail is invented precision in almost every business, and treating it as a commitment makes the plan brittle. The parts that genuinely need a three-year view are capacity, capital and capability, because those are the ones that cannot be changed inside a year.
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית